Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-042619
Filing Date
2021-08-09
Accepted
2021-08-09 16:06:17
Documents
66
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cue-10q_20210630.htm   iXBRL 10-Q 1882111
2 EX-31.1 cue-ex311_7.htm EX-31.1 16413
3 EX-31.2 cue-ex312_8.htm EX-31.2 16670
4 EX-32.1 cue-ex321_6.htm EX-32.1 10513
5 GRAPHIC grqkkghdqr0h000001.jpg GRAPHIC 67482
  Complete submission text file 0001564590-21-042619.txt   6989204

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cue-20210630.xsd EX-101.SCH 54341
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cue-20210630_cal.xml EX-101.CAL 40298
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cue-20210630_def.xml EX-101.DEF 186943
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cue-20210630_lab.xml EX-101.LAB 415660
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cue-20210630_pre.xml EX-101.PRE 323889
11 EXTRACTED XBRL INSTANCE DOCUMENT cue-10q_20210630_htm.xml XML 1090616
Mailing Address 21 ERIE STREET CAMBRIDGE MA 02139
Business Address 21 ERIE STREET CAMBRIDGE MA 02139 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

EIN.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38327 | Film No.: 211156466
SIC: 2834 Pharmaceutical Preparations